Page 7 - BRIP ePoster Book
P. 7

THE EFFECT OF PINOCEMBRIN ON IMPAIRED MITOCHONDRIAL BIOENERGETICS ASSOCIATED WITH
 DOXORUBICIN ADMINISTRATION IN AN MCF-7 CELL MODEL
 Nonhlakanipho F. Sangweni, Lawrence Mabasa, Derick van Vuuren, Barbara Huisamen, Rabia Johnson
 Background  Results                             Table 1: Normalized mitochondrial flux ratios

 Oxidative phosphorylation
 During chemotherapy, distinct
 bioenergetics dysfunction in cancer   A  B  Basal respiration
 mitochondrial subpopulations may be   400  Oligo  FCCP  Rot + Ant A  200
 OCR (pmol/min/ug protein)  200  OCR (pmol/min/ug protein)  100  aaa
 reversed by the co-administrative use   ***
 of Doxorubicin (Dox) with   300  150  ***
 cardioprotective agents.

 100
         50
 0 0  10  20  30  40  50  60  70  80  0               Mitochondrial membrane potential
           Control  Pin  Dox
 Time (min)                  Dox + Pin

 AIM  C  150  ATP linked respiration  D  250  Spare respiratory capacity
 ***
 To assess the degree of impaired mitochondrial function associated with the  200  **  **  G
 combined use of Dox plus Pinocembrin (Pin), using an MCF-7 breast cancer  100  aa  150  4
 cell model  OCR (pmol/min/ug protein)  OCR (pmol/min/ug protein)  100  aaa  3  ***

 Methodology  50  aaa  50                             Mitochondrial potential (AU)  2
 1  0      0                                                                  aaa
 MCF-7 Cells                                            1               aaa
 Control  Pin  Dox  Dox + Pin  Control  Pin  Dox  Dox + Pin  0

                                                                  Pin
 E  40  ATP turnover  F 400  Maximal respiration          Control  Conclusion Dox  Dox + Pin
 OCR (pmol/min/ug protein)  30  aa  OCR (pmol/min/ug protein)  300  ***  aaa  aaa  Although Pin, as an adjunct to Dox, influenced the respiratory
 ***


         200
 20
                                       parameters of the cancer cells, this effect was not sufficient to
         100
                                       ameliorate the cells mitochondrial function as determined by the
 10
 Group 1  Group 2  0  0                reduced mitochondrial flux ratios and potential (ΔΨm).
 2  Control  Pin  Dox  Control  Pin  Dox                  Acknowledgements
 Control  Dox   Dox + Pin     Dox + Pin
 Pin  Dox + Pin                         Reenen Barry, Bio-Pharm New Zealand,
                                        SAMRC Research Capacity Development PhD Internship Program,
 aa p < 0.01,  aaa p < 0.001 compared to control, and ** p < 0.01,  ***p < 0.001 compared to Dox. Results expressed as   Biomedical Research and Innovation Platform
 mean ± SEM
   2   3   4   5   6   7   8   9   10   11   12